Permanent foramen ovale: when to close?

Size: px
Start display at page:

Download "Permanent foramen ovale: when to close?"

Transcription

1 Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France

2 PFO - Pathology TEE

3 PFO - Anatomy & Pathology FOP Thrombus TEE

4 PFO - Cryptogenic strokes - Patients <55 yrs OverellJR et al. Neurology 2000;55:1172-9

5 PFO + ASA OverellJR et al. Neurology 2000;55:1172-9

6 FOP-ASA: Recurrent stroke Mas et al N Engl J Med 2001;345: yr (IC 95%) 2 yrs (IC 95%) 3 yrs (IC 95%) 4 yrs (IC 95%) Mean annual risk No PFO no ASA 2.0 ( ) 3.7 ( ) 4.2 ( ) 4.2 ( ) 1.1 PFO only 1.8 ( ) 1.8 ( ) 2.3 ( ) 2.3 ( ) 0.6 ASA only PFO + ASA 2.0 (0-5.8) 4.0 (0-9.4) 6.3 (0-13.2) 15.2 ( ) 4.0 <55 y-o, all on Aspirin 300 mg/d

7 PFO an Recurrent Stroke Meta-analysis Almekhlafi MA et al. Neurology 2009;73:89-97

8

9 Case y-o man no risk factor sudden acute left pure motor hemiparesis DWI paramedian pontine infarct normal work-up: TCD, Duplex, MRA, ECG TEE : PFO

10 High-Resolution MRI of the basilar artery Paramedian Pontine Infarcts (branch disease) Klein, Lavallée, Amarenco. Neurology 2005;64:

11 Case y-o man sudden pure motor right-sided hemiparesis with dysarthria Total recovery within 8 days 1 year before: dysarthria and clumsy hand, totally regressive MRI: old small infarct in the corona radiata and new capsular infarct ECG: sinus rhythm TCD and Carotid duplex normal MRA extra/intracranial: normal TEE: PFO and ASA

12 Small Deep Atherothrombotic Brain Infarct

13 Lacune Arterioles < µm Lipid deposits Lipohyalinosis Hyalinosclerosis

14 Case - 3 PFO in the young A 25 y-o woman had a long flight from Sydney to Paris. The day after she woke up with a fronto-orbital headache. Self treatment with a triptan with weak success In the evening: massive, dense left-sided hemiplegia with total resolution within 2 hours Work-up negative: TCD, Carotid duplex, MRI, MRA, ECG, no hypercoagulation TEE : PFO and ASA

15 Case - 3 Fat-saturated MRI

16 Case y-o man woke up at 4:00 am with severe occipital headache Unsteadiness of walk Day after: ER: left sided dysmetria and cerebellar ataxia BP 136/88 Ultrasound ex: carotid normal, low flow in V3, normal basilar artery, hypoplastic right VA MRI: acute SCA infarct MRA and XRA normal except right VA hypoplastic TEE : FOP + ASA

17 Case - 4 Follow-up HR-MRI on day 18

18 Wrong PFO Closure

19 What is a «cryptogenic stroke» or «stroke of indetermined cause»?

20 CAUSES of STROKE Stroke 80% 20% Ischemic Hemorrhagic Large Artery Atherosclerosis Cardiac Sources Small Artery Disease Dissection and other causes Unknown cause 20% 15% 25% 2 à 3% 30-40%

21 Usual classification systems Consider only the most likely cause Neglect other possible, or potential cause Neglect non causally related underlying disease - e.g., MRI evidences of small vessel changes such as severe leukoaraiosis - e.g., documented atherosclerotic disease in arteries not supplying teh ischemic field) When two causes co exist, they are classified into one mixed group of «unknown cause», including: Cases with co existing actual causes Cases with insufficient work-up Cases with thorough work-up but with no cause detected

22 Usual classification systems Based on these classification systems, publications looking at new potential cause or biomarker, or genetic association studies analyze 5 «rigid» groups : LAA, SVD, CE, Other and Unknown causes

23 A-S-C-0 Findings in each patient are described by an ASCO «code» A: atherothrombosis S: small vessel disease C: cardiac embolism O: other cause Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. A new approach to stroke subtyping : the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis ;27 :

24 A-S-C-0 Each of the 4 A-S-C-O is graded: 1: Definitely a potential cause of the index stroke 2: Causality uncertain 3: Unlikely a direct cause of the index stroke (but disease is present) 0: no evidence of disease 9: insufficient work-up to grade

25 AMISTAD cohort (preliminary on the first 103 patients among 650) Distribution using TOAST 18% co-existing causes

26 ASCO vs. TOAST Among 52 pts classified «Undetermined cause» by TOAST Athero Small vessel Cardiac

27 TOAST vs ASCO Analysis: out of 103 cases TOAST: proportion of SVD n=10 [but UND n=7 (LAA+CE+SVD n=3, CE+SVD n=4)] ASCO: proportion of SVD n=48 [S1 (n=14), S2 (N=6), S3 (28)] S0 n=49 S9 n=6 Analysis: out of 103 cases TOAST: proportion of LAA n=15 [but UND n=15 (LAA+CE n=12, LAA+CE+SVD n=3)] ASCO: proportion of LAA n=86 [A1 (n=25), A2 (N=22), A3 (39)] A0 n=16 A9 n=1

28 ECG monitoring in SUC Elijovich L, Josephson SA, Fung GL, Wmith WS. J Stroke Cerebrovasc Dis. 2009;18(3): Ischemic Stroke 36 SUC 20 SUC evaluated with 30 days cardiac event monitor 4 (20%) Atrial fibrillation When it is not atrial fibrillation, it can be. atrial fibrillation

29 Detection of AF Telemetry: 4 to 8% 24hr Holter ECG 1% to 5% Pts with >7 premature atrial beats/24 hr on initial holter had a 26% occurrence of AF if monitoring is extended to 7 days 30 days event recorder (new generation): automatic detection of brady or tachy-arrhythmias 149 pts: 5.7% (mean monitoring duration 159 hrs) 60 pts: 6.7% (70.1±30.9 hrs) 56 pts: 23% (21 days) Implantable loop recorder (14 months monitoring) No available evidences

30

31 Conclusions PFO associated with thrombus is likely a source of cerebral embolism PFO is more frequent in patients with TIA/Stroke of unknown cause PFO may increase the risk of recurrent stroke, but this will only be proven by randomised trials conducted in patients with stroke of unknown cause However, the diagnosis of stroke of unknown cause is very difficult Undetected atrial fibrillation is likely underestimated The role of atherosclerotic disease is underestimated Small vessel disease is highly prevalent Carotid or vertebral artery dissection in the young must be thoroughly search for in patients younger than 60 years

32 Take home message cryptogenic stroke is the most difficult diagnosis to make Consider PFO + ASA as a potential cause only if you are confident with your negative workup Efficacy of PFO closure in this context remains to be proven

33 Conclusions Pending a RCT comparing aspirin, anticoagulant and PFO closure PFO alone : annual risk 0.6% -->aspirin PFO alone and Recurrent (true) cryptogenic --> PFO closure vs. OA PFO + DVT or PE: PFO closure vs. OA

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Cryptogenic Stroke: What Don t We Know Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Financial Disclosures None Objectives Principles of diagnostic evaluation

More information

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical

More information

Speakers. 2015, American Heart Association 1

Speakers. 2015, American Heart Association 1 Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,

More information

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

What the general cardiologist should know about arrhythmia Stroke prevention in AF Peter Ammann Kantonsspital St. Gallen What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen What the cardiologist should know about arrhythmia and stroke are there real low

More information

Cryptogenic Stroke: A logical approach to a common clinical problem

Cryptogenic Stroke: A logical approach to a common clinical problem Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific

More information

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and

More information

New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke

New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke Original Paper DOI: 10.1159/000210433 Received: February 2, 2009 Accepted: February 2, 2009 Published online: April 3, 2009 New Approach to Subtyping: The A-S-C-O (Phenotypic) Classification of P. Amarenco

More information

Cryptogenic Strokes: Evaluation and Management

Cryptogenic Strokes: Evaluation and Management Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG

More information

Patent Foramen Ovale: Diagnosis and Treatment

Patent Foramen Ovale: Diagnosis and Treatment Patent Foramen Ovale: Diagnosis and Treatment Anthony DeMaria Judy and Jack White Chair in Cardiology University of California, San Diego At one time or another a Grantee, Sponsored Speaker or Ad-hoc Consultant

More information

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real PFO Closure: Where We Are Going to after CLOSURE I Study? Issam D. Moussa, MD Professor of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida Disclosure Statement of

More information

How to Evaluate Patients with Cryptogenic Stroke

How to Evaluate Patients with Cryptogenic Stroke How to Evaluate Patients with Cryptogenic Stroke Jeffrey Saver, MD Professor of Neurology Director, How to Evaluate Patients with Cryptogenic Stroke Disclosure Scientific Consultant, Unpaid Trialist: AGA

More information

Management and Investigation of Ischemic Stroke By Etiology

Management and Investigation of Ischemic Stroke By Etiology Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke

More information

PFO Management update

PFO Management update PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

More information

True cryptogenic stroke

True cryptogenic stroke True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

More information

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

How Can We Properly Manage Patients With Stroke of Undetermined Origin? How Can We Properly Manage Patients With Stroke of Undetermined Origin? : Spotlight on Embolic Stroke of Undetermined Source (ESUS) MI SUN OH Department of Neurology, Hallym University Scared Heart Hospital,

More information

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this

More information

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

Basilar Artery Atherosclerotic Plaques in Paramedian and Lacunar Pontine Infarctions A High-Resolution MRI Study

Basilar Artery Atherosclerotic Plaques in Paramedian and Lacunar Pontine Infarctions A High-Resolution MRI Study Basilar Artery Atherosclerotic Plaques in Paramedian and Lacunar Pontine Infarctions A High-Resolution MRI Study Isabelle F. Klein, MD, PhD; Philippa C. Lavallée, MD; Mikael Mazighi, MD, PhD; Elisabeth

More information

Small Vessel Stroke. Domenico Inzitari Careggi University Hospital Florence (Italy)

Small Vessel Stroke. Domenico Inzitari Careggi University Hospital Florence (Italy) Small Vessel Stroke Domenico Inzitari Careggi University Hospital Florence (Italy) Topics Lacunar stroke The small vessel conundrum Small and large Conclusions Fisher s lacunar syndromes Pure motor hemiparesis

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to

More information

Supplementary webappendix

Supplementary webappendix Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hart RG, Diener H-C, Coutts SB, et al,

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic

More information

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia GROUPE HOSPITALIER BICHAT-CLAUDE BERNARD PARIS DIDEROT UNIVERSITY - PARIS 7 Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia Pierre Amarenco INSERM U-698 and Denis

More information

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man Stroke Topics Advances in the Prevention and Treatment of Stroke August 10, 2009 John W. Engstrom, M.D. Professor of Neurology Acute treatment options for ischemic stroke tpa, clot retraction, future directions

More information

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION The Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease

More information

GERIATRICS CASE PRESENTATION

GERIATRICS CASE PRESENTATION GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone

More information

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

More information

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline

More information

TIA: Updates and Management 2008

TIA: Updates and Management 2008 TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose

More information

PFO Closure for the Management of Migraine and Stroke

PFO Closure for the Management of Migraine and Stroke PFO Closure for the Management of Migraine and Stroke Sun U. Kwon Department of Neurology, Asan Medical Center, UUMC Contents PFO & Migraine PFO causes Migraine or Not? PFO closure for Migraine PFO & Stroke

More information

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE Matthew Starr, MD Stroke Attending DISCLOSURES None DEBATE Should PFO be closed? * * Sometimes yes THE CASE AGAINST PFO CLOSURE 1. Did the PFO cause the

More information

Cryptogenic Stroke: The role of silent Atrial Fibrillation

Cryptogenic Stroke: The role of silent Atrial Fibrillation Cryptogenic Stroke: The role of silent Atrial Fibrillation PD Dr. med. Martin A. Ritter Westfälische Wilhelms-Universität Münster Germany ritterm@uni-muenster.de 1 Turin, 25.10.2014 Agenda 1. What is a

More information

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on 6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

More information

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do?

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do? Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do? Robert J. Sommer, MD Columbia University Medical Center New York, NY Disclosure Statement of Financial Interest Within the past

More information

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE: 2017 Cardiovascular Symposium A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE CRYPTOGENIC: OF OBSCURE OR UNKNOWN

More information

TOP 3: EMBRACE. Lucy Vieira MD FRCP Neurologist MUHC. N Engl J Med Volume 370(26): June 26, David J.

TOP 3: EMBRACE. Lucy Vieira MD FRCP Neurologist MUHC. N Engl J Med Volume 370(26): June 26, David J. TOP 3: EMBRACE N Engl J Med Volume 370(26):2467-2477 June 26, 2014 David J. Gladstone et al Lucy Vieira MD FRCP Neurologist MUHC Receiving research funds AstraZeneca 2014-2016 Original Article Atrial Fibrillation

More information

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.

More information

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the

More information

Nicolas Bianchi M.D. May 15th, 2012

Nicolas Bianchi M.D. May 15th, 2012 Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the

More information

Overlap of Diseases Underlying Ischemic Stroke The ASCOD Phenotyping

Overlap of Diseases Underlying Ischemic Stroke The ASCOD Phenotyping Overlap of Diseases Underlying Ischemic Stroke The ASCOD Phenotyping Gaia Sirimarco, MD; Philippa C. Lavallée, MD; Julien Labreuche, BST; Elena Meseguer, MD; Lucie Cabrejo, MD; Céline Guidoux, MD; Isabelle

More information

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke

More information

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate? Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University

More information

Management of Atrial Fibrillation. Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018

Management of Atrial Fibrillation. Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018 Management of Atrial Fibrillation Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018 Disclosures Speaker: St. Jude Medical, Biotronik Consultant: St. Jude Medical, World Care Clinical Objectives Recognize

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with Non-fluent dysphasia R facial weakness Background Ischaemic heart disease Hypertension Hyperlipidemia L MCA branch

More information

Antithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel

Antithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel Antithrombotic Summit Basel 2012 Basel, 26. April 2012 Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel Background stroke = third-leading cause of death among adults 1/5 of stroke survivors require

More information

TIA triage in Not all that glitters is gold

TIA triage in Not all that glitters is gold TIA triage in 2016 Not all that glitters is gold Disclosures No industry related disclosures Expert witness work Overview Definition Implications Guidelines, secondary prevention Implementation of guidelines

More information

Cryptogenic Stroke: Finding Light in the Darkness

Cryptogenic Stroke: Finding Light in the Darkness Cryptogenic Stroke: Finding Light in the Darkness Scott E. Kasner, MD Professor of Neurology Director, Comprehensive Stroke Center Disclosures WL Gore PI for Gore REDUCE Trial Medtronic DSMB for CRYSTAL

More information

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Cathy Sila MD George M Humphrey II Professor and Vice Chair of Neurology Director, Comprehensive Stroke Center

More information

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect

Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect Qualifying and Outcome Strokes in the RESPECT PFO Trial: Additional Evidence of Treatment Effect JEFFREY L. SAVER, MD DAVID E. THALER, MD, PHD, RICHARD W. SMALLING, MD, PHD, JOHN D. CARROLL, MD, SCOTT

More information

CLOSE. Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence

CLOSE. Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence CLOSE Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence Guillaume TURC, MD, PhD Paris Descartes University Sainte-Anne hospital Paris, France On

More information

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018 Stroke Stroke Megan Stevens MD Vascular Neurology SUDDEN Maximal at onset Lateralized weakness, lateralized numbness, vision loss (one eye or portion of field in both eyes), double vision, slurred speech,

More information

PFO closure group total no. PFO closure group no. of males

PFO closure group total no. PFO closure group no. of males Suppl Table. Characteristics of the five trials included in this meta-analysis. Trial name Device used for Definition of medical Primary Endpoint group total no. group no. of males group age (yrs) group

More information

Michael Horowitz, MD Pittsburgh, PA

Michael Horowitz, MD Pittsburgh, PA Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion

More information

10/19/12. Uncommon Causes of Stroke. José Biller, MD, FACP, FAAN, FAHA Disclosures. Dr. Biller has no disclosures to report

10/19/12. Uncommon Causes of Stroke. José Biller, MD, FACP, FAAN, FAHA Disclosures. Dr. Biller has no disclosures to report 10/19/12 Uncommon Causes of Stroke José Biller, MD, FACP, FAAN, FAHA Loyola University Chicago Stritch School of Medicine Chicago, IL José Biller, MD, FACP, FAAN, FAHA Disclosures Dr. Biller has no disclosures

More information

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE ESUS Progression of haematoma Anticoagulation Large ICH

More information

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute Ischemic stroke: management, prevention and follow up Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute Quotes Benjamin Franklin: All would live long, but none would be old.

More information

2018 Update in Diagnosis and Management of Stroke

2018 Update in Diagnosis and Management of Stroke 2018 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Chair, Department of Neurology Director,

More information

TIA as Acute Cerebrovascular Syndrome

TIA as Acute Cerebrovascular Syndrome TIA as Acute Cerebrovascular Syndrome Frontiers of Neurology and Neuroscience Vol. 33 Series Editor J. Bogousslavsky Montreux TIA as Acute Cerebrovascular Syndrome Volume Editors S. Uchiyama Tokyo P. Amarenco

More information

DIFFERENT STROKES FOR DIFFERENT FOLKS!!

DIFFERENT STROKES FOR DIFFERENT FOLKS!! DIFFERENT STROKES FOR DIFFERENT FOLKS!! Identifying Stroke Subtypes SWAROOP PAWAR M.D., MPH. Vascular Neurologist UMG Neuroscience Associates Greenville Health System None Disclosures Outline Stroke, TIA

More information

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.

More information

Why Should We Treat PFO?

Why Should We Treat PFO? Why Should We Treat PFO? SCAI Interventional Cardiology Fellows Course December 7, 2012 Jonathan Tobis, MD Director of Interventional Cardiology UCLA Disclosures Jonathan Tobis, MD 1. A Principal Investigator

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

CT and MR Imaging in Young Stroke Patients

CT and MR Imaging in Young Stroke Patients CT and MR Imaging in Young Stroke Patients Ashfaq A. Razzaq,Behram A. Khan,Shahid Baig ( Department of Neurology, Aga Khan University Hospital, Karachi. ) Abstract Pages with reference to book, From 66

More information

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism Luigi P. Badano, MD, FESC Background Stroke is the 3 cause of death in several industrial countries; Embolism accounts for 15-30%

More information

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health INTRODUCTION Three recently published randomized controlled trials in The New England Journal of Medicine provide new information about closure

More information

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M.

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M. FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M. Bufalini - Cesena FORAME OVALE PERVIO ICTUS CRIPTOGENETICO FORAME OVALE PERVIO

More information

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory

The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory Oh Young Bang, M.D., Jeong Hoon Cho, M.D., Ji Hoe Heo, M.D., Dong Ik Kim, M.D.* Department

More information

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist 1 One Strategy for cryptogenic stroke: ESUS Positively defined criteria FDA allows clinical trials NOACs have lower risk profile Another strategy

More information

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one: MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL 2014-15 The following is a list of variables and how to complete each one: (PHY-1) Case, per physician review: The most important task for the physicians

More information

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012 Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model

More information

RESPECT Safety Findings

RESPECT Safety Findings CO-1 SCAI Town Hall Meeting Monday, October 31, 2016 Washington, DC RESPECT Safety Findings John D. Carroll, M.D., MSCAI Professor of Medicine Cardiology University of Colorado School of Medicine University

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

Lesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt

Lesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt European Journal of Neurology 2009, 16: 1077 1082 CME ARTICLE doi:10.1111/j.1468-1331.2009.02692.x Lesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt R. Feurer a,

More information

Why Treat Patent Forman Ovale

Why Treat Patent Forman Ovale Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease Rush University Medical Center Conclusions

More information

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation 48 th Annual New York Cardiovascular Symposium Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation Is Left Atrial Appendage Dysfunction Sufficient to Generate Clots? December

More information

Lacunar Infarct. Dr. Tapas Kumar Banerjee Medical Director & Chief Consultant Neurologist National Neurosciences Centre Calcutta

Lacunar Infarct. Dr. Tapas Kumar Banerjee Medical Director & Chief Consultant Neurologist National Neurosciences Centre Calcutta Lacunar Infarct Dr. Tapas Kumar Banerjee Medical Director & Chief Consultant Neurologist National Neurosciences Centre Calcutta Aetiologies of Ischemic Stroke Atherothrombo-embolic Cardio-embolic Aetiologies

More information

Branch Atheromatous Plaque: A Major Cause of Lacunar Infarction (High-Resolution MRI Study)

Branch Atheromatous Plaque: A Major Cause of Lacunar Infarction (High-Resolution MRI Study) Original Paper EXTRA This is an Open Access article licensed under the terms of the Creative Commons Attribution- ncommercial-derivs 3.0 License (www.karger.com/oa-license), applicable to the online version

More information

Vessel Wall Imaging of Intracranial Arterial Disease Commercial Interests

Vessel Wall Imaging of Intracranial Arterial Disease Commercial Interests Vessel Wall Imaging of Intracranial Arterial Disease Commercial Interests Disclosures No relevant commercial interests Off Label / Investigational Use No off label / investigational use Daniel Mandell,

More information

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow Stroke Case Studies Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow Case 1 64 year old female with dysphasia and right arm weakness 3 hours prior CT head: dense M1 sign. No established ischaemia

More information

Secondary Stroke Prevention: A Precautionary Tale

Secondary Stroke Prevention: A Precautionary Tale Secondary Stroke Prevention: A Precautionary Tale Kirsten George-Phillips, BSP Clinical Practice Leader, AHS Clinical Pharmacist, AHS Owen Stroke Prevention Clinic Learning Objectives! Examine literature

More information

Defining Sub-Clinical Atrial Fibrillation and its management

Defining Sub-Clinical Atrial Fibrillation and its management Defining Sub-Clinical Atrial Fibrillation and its management Jeff Healey MD, MSc, FRCP, FHRS PHRI Chair in Cardiology Research Population Health Research Institute McMaster University, Canada Sub-Clinical

More information

Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack? Does Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack? Pierre Amarenco, MD; Julien Labreuche, BS; Philippa C. Lavallée, MD; Elena Meseguer, MD; Lucie Cabrejo, MD; Tarik Slaoui,

More information

Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 115 Consecutive Patients

Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 115 Consecutive Patients 5 Causes and Mechanisms of Territorial and Nonterritorial Cerebellar Infarcts in 5 Consecutive Patients Pierre Amarenco, MD; Claude Levy, MD; Ariel Cohen, MD; Pierre-Jean Touboul, MD; Etienne Roullet,

More information

Modena, 6 novembre Heart and Brain. Paolo Bovi

Modena, 6 novembre Heart and Brain. Paolo Bovi MODENA STROKE CONGRESS 2014 Modena, 6 novembre 2014 Heart and Brain Paolo Bovi Stroke Unit UO Neurologia A DAI di Neuroscienze Azienda Ospedaliera Universitaria Integrata Verona I do not say so, but at

More information

Watchman Implantation Case Presentation and Discussion

Watchman Implantation Case Presentation and Discussion Watchman Implantation Case Presentation and Discussion Walid Saliba, MD, FHRS Director Atrial Fibrillation Center Co-Director AF Stroke Prevention Center Cleveland Clinic Indication FDA NonValvular AF

More information

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012 Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management

More information

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

Critical Review Form Therapy

Critical Review Form Therapy Critical Review Form Therapy A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects, Lancet-Neurology 2007; 6: 953-960 Objectives: To evaluate the effect of

More information

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL Carmelo Cernigliaro Clinica San Gaudenzio Novara Eco 2D e 3D Eco Transesofageo Large shunt

More information

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier Procedural Outcome after Percutaneous Closure of Patent Foramen Ovale using the Amplatzer PFO Occluder Without Intra-Procedural Echocardiography in 1,000 Patients Fabien Praz, Andreas Wahl, Sophie Beney,

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination pulse 80/min reg, BP 160/95

More information

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Patients selection criteria for LAA occlusion Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Atrial Fibrillation The most common cardiac arrhythmia. Confers

More information

Embolic Stroke of Undetermined Source (ESUS) Lee Birnbaum, MD, MS Depts of Neurology and Neurosurgery UTHSCSA

Embolic Stroke of Undetermined Source (ESUS) Lee Birnbaum, MD, MS Depts of Neurology and Neurosurgery UTHSCSA Embolic Stroke of Undetermined Source (ESUS) Lee Birnbaum, MD, MS Depts of Neurology and Neurosurgery UTHSCSA Disclosures UTHSCSA Site-PI for NAVIGATE ESUS Industry sponsored by Bayer New Approach rivaroxaban

More information

Imaging Acute Stroke and Cerebral Ischemia

Imaging Acute Stroke and Cerebral Ischemia Department of Radiology University of California San Diego Imaging Acute Stroke and Cerebral Ischemia John R. Hesselink, M.D. Causes of Stroke Arterial stenosis Thrombosis Embolism Dissection Hypotension

More information

Clinical Prediction Rule for Treatment Change Based on Echocardiogram Findings in Transient Ischemic Attack and Non-Disabling Stroke

Clinical Prediction Rule for Treatment Change Based on Echocardiogram Findings in Transient Ischemic Attack and Non-Disabling Stroke Clinical Prediction Rule for Treatment Change Based on Echocardiogram Findings in Transient Ischemic Attack and Non-Disabling Stroke By ABDULAZIZ ALSADOON Submitted January 2015 Thesis submitted to the

More information

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Tarvinder Singh, MS, MD Neurohospitalist Swedish Neuroscience Institute 1 Objectives Definition Why the urgency? Evidence/Guidelines

More information

2015 Update in Diagnosis and Management of Stroke

2015 Update in Diagnosis and Management of Stroke 2015 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department

More information

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC PFO- To Close for Comfort By: Vincent J.Caracciolo, MD FACC PATENT FORAMEN OVALE PFO- congenital lesion that frequently persists into adulthood ( 25-30%)- autopsy and TEE studies. PFO prevalence higher

More information